Cargando…
Cautious optimism in anticipation of hepatitis B curative therapies
Despite relative effectiveness of current hepatitis B therapies, there is still no curative agents available. The new emerging approaches hold promise to achieve cure and loss of hepatitis B surface antigen. Studies or clinical trials investigating new therapies remain small and either focus on pati...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372785/ https://www.ncbi.nlm.nih.gov/pubmed/36159610 http://dx.doi.org/10.5501/wjv.v11.i4.212 |